MedTrace Logo

ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19

NCT04367740 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6313

Last updated 2023-01-09

No results posted yet for this study

Summary

Purpose: To determine the number of asymptomatic individuals who have antibodies to SARS-CoV-2, the virus which causes COVID-19

Conditions

  • Asymptomatic Condition
  • Infection Viral
  • Coronavirus Infections
  • Severe Acute Respiratory Syndrome Coronavirus 2
  • Coronaviridae Infections
  • RNA Virus Infections
  • Virus Diseases
  • Communicable Disease

Interventions

DIAGNOSTIC_TEST

To assess for development of IgG antibodies against SARS-CoV2

Swabs will be collected to assess for COVID-19 if PPE supplies allow.

Sponsors & Collaborators

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • David B Peden, MD · University of North Carolina, Chapel Hill

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-28
Primary Completion
2022-02-24
Completion
2022-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04367740 on ClinicalTrials.gov